PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines

A. A. Nekipelova; R. N. Alyautdin

Safety and Risk of Pharmacotherapy
Bezopasnostʹ i risk farmakoterapii

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

User

eng | рус

Safety and Risk of Pharmacotherapy

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Nekipelova A.A., Alyautdin R.N. PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines. Safety and Risk of Pharmacotherapy. 2023;11(3):279-291. https://doi.org/10.30895/2312-7821-2023-11-3-279-291

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Safety and Risk of Pharmacotherapy

For citations:

Cookies policy